^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CGS 21680

    i
    Other names: CGS 21680
    Associations
    News
    Trials
    Company:
    Novartis
    Drug class:
    Adenosine A2A receptor agonist
    Associations
    News
    Trials